These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28730960)

  • 1. Protein Kinases as Tumor Biomarkers and Therapeutic Targets.
    Quan C; Xiao J; Liu L; Duan Q; Yuan P; Zhu F
    Curr Pharm Des; 2017 Nov; 23(29):4209-4225. PubMed ID: 28730960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
    Faivre S; Djelloul S; Raymond E
    Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor Tyrosine Kinase-Targeted Cancer Therapy.
    Yamaoka T; Kusumoto S; Ando K; Ohba M; Ohmori T
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances.
    Hojjat-Farsangi M
    J Drug Target; 2016; 24(3):192-211. PubMed ID: 26211367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Protein Kinases for the Treatment of Glioblastoma Multiforme: Linking Basic Studies to Clinical Applications.
    Zhou A
    Curr Pharm Des; 2017 Nov; 23(29):4290-4302. PubMed ID: 28699529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy.
    Loilome W; Dokduang H
    Curr Pharm Des; 2017 Nov; 23(29):4281-4289. PubMed ID: 28699535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinases in PI3K signaling: The therapeutic targets in cancer.
    Jiang W; Ji M
    Semin Cancer Biol; 2019 Dec; 59():3-22. PubMed ID: 30943434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising Targets in Anti-cancer Drug Development: Recent Updates.
    Kumar B; Singh S; Skvortsova I; Kumar V
    Curr Med Chem; 2017; 24(42):4729-4752. PubMed ID: 28393696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinases as targets for cancer treatment.
    Giamas G; Stebbing J; Vorgias CE; Knippschild U
    Pharmacogenomics; 2007 Aug; 8(8):1005-16. PubMed ID: 17716234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J; Janku F
    Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
    Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer.
    Matos I; Elez E; Capdevila J; Tabernero J
    Expert Opin Emerg Drugs; 2016 Sep; 21(3):267-82. PubMed ID: 27578253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-kinase inhibitors, AURKs and cancer.
    Cicenas J; Cicenas E
    Med Oncol; 2016 May; 33(5):43. PubMed ID: 27038473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectokinases as novel cancer markers and drug targets in cancer therapy.
    Yalak G; Vogel V
    Cancer Med; 2015 Mar; 4(3):404-14. PubMed ID: 25504773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Kinase inhibitors and their resistance].
    Togashi Y; Nishio K
    Nihon Rinsho; 2015 Aug; 73(8):1323-9. PubMed ID: 26281685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive review of protein kinase inhibitors for cancer therapy.
    Kannaiyan R; Mahadevan D
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1249-1270. PubMed ID: 30259761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting receptor tyrosine kinases in solid tumors.
    Zhang J; Hochwald SN
    Surg Oncol Clin N Am; 2013 Oct; 22(4):685-703. PubMed ID: 24012395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinases as molecular targets to inhibit cancer progression and metastasis.
    Cepero V; Sierra JR; Giordano S
    Curr Pharm Des; 2010; 16(12):1396-409. PubMed ID: 20166985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.